Cytokeratin 3 Antibody (Mouse mAb) [N24P21]

Catalog No.: F2198

    Application: Reactivity:

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:800
    Application
    IHC
    Source
    Mouse Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    64 kDa 65 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。

    Datasheet & SDS

    生物学的記述

    Specificity
    Cytokeratin 3 Antibody (Mouse mAb) [N24P21] detects endogenous levels of total Cytokeratin 3/CK-3 protein.
    Clone
    N24P21
    Synonym(s)
    65 kDa cytokeratin, Cytokeratin-3, Keratin-3, Type-II keratin Kb3, CK-3, K3, KRT3
    Background
    Cytokeratin 3 (CK3, gene KRT3) is a type II intermediate filament keratin that forms an obligate heteropolymeric pair with the type I keratin K12 to build the cornea-specific cytoskeletal scaffold in differentiated corneal epithelium. This network supports mechanical resilience, barrier function, and the maintenance of corneal transparency by anchoring to desmosomal and hemidesmosomal complexes and integrating with the epithelial basement membrane. CK3/K12 filaments assemble into a dense cytoplasmic lattice whose organization depends on highly conserved helix boundary motifs and the glycine-rich tail domain—regions that mediate longitudinal filament assembly and lateral filament–filament packing. Even single amino-acid substitutions in these motifs can alter filament stability and increase susceptibility to mechanical shear. Within the corneal epithelium, this keratin pair defines the differentiated suprabasal compartment, marking the transition from limbal progenitors to mature central epithelial cells and coupling cytoskeletal status to junctional complexes that stabilize epithelial sheets and preserve an optically smooth surface. Pathogenic missense mutations in KRT3, particularly those affecting the helix boundary and glycine-loop regions, disrupt heteropolymer assembly with K12, generate keratin aggregates, and weaken the intermediate filament network. This results in epithelial cell fragility, microcyst formation, and recurrent erosions characteristic of Meesmann corneal dystrophy, demonstrating how precise CK3 structure–function relationships can translate into tissue-level mechanical failure. Genetic linkage and sequencing studies show that disease-associated KRT3 variants segregate with Meesmann corneal dystrophy in affected families and are absent from unaffected controls. Different mutations in either KRT3 or KRT12 can produce a similar phenotype by compromising the same filament-stabilizing motifs, reinforcing the concept that corneal epithelial integrity depends on balanced expression and correct pairing of this keratin duo. CK3 also functions as a corneal epithelial lineage marker. Immunohistochemical detection of CK3/CK12 defines cornea-type differentiation and reveals altered expression or mislocalization of these keratins in certain corneal dystrophies. Changes in CK3 levels after chemical injury or epithelial loss correlate with shedding and re-epithelialization dynamics, linking its expression pattern to injury responses and epithelial renewal.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください